Personalis Presents NeXT Personal ctDNA Data At AACR 2026 Showing 100% Sensitivity In Colorectal Cancer Monitoring
Benzinga Newsdesk 6 months ago
News
Podium presentation on NeXT Personal monitoring neoadjuvant therapy in colorectal cancer;Real-world data from 10,000 patients reinforce industry-leading sensitivity;Data presented for a new NeXT Personal feature for
- Podium presentation on NeXT Personal monitoring neoadjuvant therapy in colorectal cancer;
- Real-world data from 10,000 patients reinforce industry-leading sensitivity;
- Data presented for a new NeXT Personal feature for monitoring resistance mutations